GI Oncology News & Articles

Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.

On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

D Scott Cunningham MD, PhD
Site Editor, MDLinx
Markers of obesity and inflammation in postmenopausal breast cancer

Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage

Smartest Doc Challenge
MDLinx
Melanoma Clinical Pearls

MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools

MDLinx Top Read
MDLinx
Running from that pile of unread journals?

New!	>> Find out who is the Smartest Doc in Oncology!

Articles

Latest (10) Full Text Articles (274) Focus on Lung

Ranked, sorted, and summarized by MDLinx editors from the latest literature

Topics:

141 Endoscopic Mucosal Resection Results in Change of Histologic Diagnosis in Barretts Esophagus Patients with Visible and Flat Neoplasia: A Multicenter Cohort Study Digestive Diseases and Sciences, May 3, 2013 Clinical Article

142 MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination Cancer Chemotherapy and Pharmacology, May 3, 2013 Clinical Article

143 Overexpression of carbonic anhydrase II and Ki-67 proteins in prognosis of gastrointestinal stromal tumors Full Text World Journal of Gastroenterology, May 3, 2013 Review Article

144 Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma Full Text World Journal of Gastroenterology, May 3, 2013 Review Article

145 Association between FAS-1377 G/A polymorphism and susceptibility to gastric cancer: evidence from a meta-analysis Tumor Biology, May 3, 2013 Evidence Based Medicine

146 Does Morbid Obesity Worsen Outcomes After Esophagectomy? Annals of Thoracic Surgery, May 3, 2013 Clinical Article

147 Treatment of gastric MALT lymphoma with a focus on Helicobacter pylori eradication International Journal of Hematology, May 3, 2013 Review Article Clinical Article

148 Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective European Journal of Gastroenterology & Hepatology, May 3, 2013 Clinical Article

149 Value of 18F-FDG PET/CT in the diagnosis of primary gastric cancer via stomach distension European Journal of Radiology, May 3, 2013 Clinical Article

150 Computed Tomography Scan as a Tool to Predict Tumor T Category in Resectable Esophageal Squamous Cell Carcinoma Annals of Thoracic Surgery, May 3, 2013 Clinical Article

151 Short and Long-Term Outcomes After Esophagectomy for Cancer in Elderly Patients Annals of Thoracic Surgery, May 3, 2013 Review Article

152 Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma Journal of Surgical Oncology, May 3, 2013 Clinical Article

153 Anal and perianal squamous carcinomas and high-grade intraepithelial lesions exclusively associated with low-risk HPV genotypes 6 and 11 International Journal of Cancer, May 2, 2013

154 Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients Journal of Cancer Research & Clinical Oncology, May 2, 2013 Clinical Article

155 Factors Associated With Outcomes and Response to Therapy in Patients With Infiltrative Hepatocellular Carcinoma Clinical Gastroenterology and Hepatology , May 2, 2013 Clinical Article

156 Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells International Journal of Cancer, May 2, 2013 Clinical Article

157 Identification of hepatic microvascular adhesion-related genes of human colon cancer cells using random homozygous gene perturbation International Journal of Cancer, May 2, 2013 Clinical Article

158 Emodin regulating excision repair cross-complementation group 1 through fibroblast growth factor receptor 2 signaling Full Text World Journal of Gastroenterology, May 2, 2013 Review Article

159 New-style laparoscopic and endoscopic cooperative surgery for gastric stromal tumors Full Text World Journal of Gastroenterology, May 2, 2013 Clinical Article

160 Short-Form CDYLb but not long-form CDYLa functions cooperatively with histone methyltransferase G9a in hepatocellular carcinomas Genes, Chromosomes and Cancer, May 2, 2013 Clinical Article

50 available pages First Previous 8 9 10 11 12 13 14 15 16 17 Next Last

Clinical Pearls in Oncology

The ZORO study demonstrated that the addition of goserelin to neoadjuvant chemotherapy for early breast cancer in premenopausal women resulted in no change in post-chemotherapy rates of amenorrhea
A little over 50% of tumors in women with ER-positive, node-negative breast cancers will have a RS <18, and current data suggests that these women are UNLIKELY to receive a benefit from adjuvant chemotherapy
In patients with completely resected ER-positive DCIS when the surgical specimen also has LCIS, consider breast MRI screening in addition to mammography due to the lower sensitivity of mammograms for lobular disease

» Test your knowledge. Take the Smartest Doc challenge today!

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.

Read the article summary

HCC risk increased in patients with AIDS

As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.

Read the article summary

RAB25 is a prognostic marker for ovarian cancer

As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top Articles of 2012

1 Safety and efficacy of calcium and magnesium infusions in the chemoprevention of oxaliplatin induced sensory neuropathy in digestive tract cancers: A meta-analysis Journal of Digestive Diseases, March 18, 2013

2 Long-term outcome of palliative therapy for gastric outlet obstruction caused by unresectable gastric cancer in patients with good performance status: endoscopic stenting versus surgery Gastrointestinal Endoscopy, April 8, 2013

3 Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial Annals of Oncology, April 4, 2013

4 Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial The Lancet Oncology, April 12, 2013

5 Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy Annals of Oncology, April 19, 2013

6 Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal dissemination Cancer Chemotherapy and Pharmacology, April 1, 2013

7 Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial The Lancet Oncology, April 23, 2013

8 Meat, fish, and esophageal cancer risk: a systematic review and dose-response meta-analysis Nutrition Reviews, April 16, 2013 Evidence Based Medicine Review Article

9 The safety and efficacy of peginterferon plus ribavirin in hepatitis C patients concomitant with malignancy other than hepatocellular carcinoma: a multicenter study Hepatology International, March 25, 2013

10 Efficacy, safety, and pharmacokinetics of imatinib dose escalation to 800mg/day in patients with advanced gastrointestinal stromal tumors Investigational New Drugs, April 18, 2013

11 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis (HIPEC): the Danish experience Colorectal Disease, March 11, 2013

12 Robot Versus Laparoscopic Gastrectomy for Cancer by an Experienced Surgeon: Comparisons of Surgery, Complications, and Surgical Stress Annals of Surgical Oncology, March 26, 2013

13 Laparoscopic versus open resection of gastrointestinal stromal tumors of the stomach Surgical Endoscopy, April 15, 2013

14 Neoadjuvant Chemotherapy for Gastric Cancer: A Meta-Analysis of Randomized Controlled Trails Journal of Gastroenterology and Hepatology, March 5, 2013 Evidence Based Medicine Review Article

15 Changing patterns of anal canal carcinoma in the United States Journal of Clinical Oncology, March 22, 2013

16 A comparison of three treatment strategies for locally advanced and borderline resectable pancreatic cancer Journal of Gastrointestinal Oncology, April 26, 2013 Free full text

17 Treatment of hepatocellular carcinoma in Child-Pugh B patients Digestive and Liver Diseases, April 29, 2013

18 Vitamin D and the Epidemiology of Upper Gastrointestinal Cancers: A Critical Analysis of the Current Evidence Cancer Epidemiology, Biomarkers & Prevention, April 9, 2013 Evidence Based Medicine

19 Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial The Lancet Oncology, April 26, 2013

20 Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial The Lancet Oncology, April 23, 2013

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

GI Oncology News & Articles

Articles

Clinical Pearls in Oncology

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

HCC risk increased in patients with AIDS

RAB25 is a prognostic marker for ovarian cancer

Most Popular Oncology Articles

Other Topics in Oncology